Close Menu

NEW YORK (360Dx) – Randox Laboratories today announced a £50 million ($70 million) investment to develop new diagnostic technologies aimed at ailments including cancer, heart conditions, and infectious diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.